Cytovale is a pioneering medical diagnostics company focused on transforming the detection of rapidly progressing, immune-mediated diseases. With its flagship product, IntelliSep, Cytovale offers the first and only stand-alone sepsis detection assay that enables quick and accurate risk stratification through a biomechanical evaluation of white blood cells, delivering results in under 10 minutes. This innovation significantly enhances clinical decision-making in emergency settings, positioning Cytovale as a leader in the healthcare diagnostics industry.